Experimental evaluation of icodextrin delivery as pressurized aerosol (PIPAC): Antiadhesive and cytotoxic effects

Ahmad, 2020, Barrier agents for adhesion prevention after gynaecological surgery, Cochrane Database Syst Rev, 3, CD000475 Robb, 2014, Strategies in the prevention of the formation of postoperative adhesions in digestive surgery: a systematic review of the literature, Dis Colon Rectum, 57, 1228, 10.1097/DCR.0000000000000191 Ten Broek, 2014, Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis, Lancet, 383, 48, 10.1016/S0140-6736(13)61687-6 Htay, 2018, Biocompatible dialysis fluids for peritoneal dialysis, Cochrane Database Syst Rev, 10, CD007554 Klink, 2013, Influence of 4% icodextrin solution on peritoneal tissue response and adhesion formation, BMC Surg, 13, 34, 10.1186/1471-2482-13-34 van den Tol, 2005, Icodextrin reduces postoperative adhesion formation in rats without affecting peritoneal metastasis, Surgery, 137, 348, 10.1016/j.surg.2004.06.001 Matsumoto, 2012, Impacts of icodextrin on integrin-mediated wound healing of peritoneal mesothelial cells, Life Sci, 90, 917, 10.1016/j.lfs.2012.04.036 Sakari, 2016, Role of icodextrin in the prevention of small bowel obstruction. Safety randomized patients control of the first 300 in the ADEPT trial, Colorectal Dis, 18, 295, 10.1111/codi.13095 Trew, 2011, Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery, Hum Reprod, 26, 2015, 10.1093/humrep/der135 Al Dybiat, 2020, Injured tissues favor cancer cell implantation via fibrin deposits on scar zones, Neoplasia, 22, 809, 10.1016/j.neo.2020.09.006 Urkan, 2017, Prevention of intraabdominal adhesions: an experimental study using mitomycin-C and 4% icodextrin, Balkan Med J, 34, 35, 10.4274/balkanmedj.2015.1359 Jouvin, 2017, Reduction of carcinomatosis risk using icodextrin as a carrier solution of intraperitoneal oxaliplatin chemotherapy, Eur J Surg Oncol, 43, 1088, 10.1016/j.ejso.2016.12.009 Flessner, 2016, Pharmacokinetic problems in peritoneal drug administration: an update after 20 years, Pleura Peritoneum, 1, 183, 10.1515/pp-2016-0022 Argentino, 2014, Imaging of the peritoneum evaluated by 99mTc-icodextrin scintigraphy in peritoneal dialysis patients: preliminary data, Blood Purif, 38, 219, 10.1159/000366553 Nadiradze, 2019, Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy (PIPAC), Cancers (Basel), 12, 10.3390/cancers12010034 Eveno, 2017, Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy, Pleura Peritoneum, 2, 103, 10.1515/pp-2017-0015 Khosrawipour, 2017, Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells, World J Surg Oncol, 15, 43, 10.1186/s12957-017-1109-4 Davigo, 2020, PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model, Int J Hyperther, 37, 144, 10.1080/02656736.2019.1704891 Giger-Pabst, 2019, Comparison of tissue and blood concentrations of oxaliplatin administrated by different modalities of intraperitoneal chemotherapy, Ann Surg Oncol, 26, 4445, 10.1245/s10434-019-07695-z Solass, 2014, Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy, Ann Surg Oncol, 21, 553, 10.1245/s10434-013-3213-1 Tempfer, 2018, Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis, Eur J Surg Oncol, 44, 1112, 10.1016/j.ejso.2018.04.020 Shariati, 2019, High pressure nebulization (PIPAC) versus injection for the intraperitoneal administration of mRNA complexes, Pharm Res, 36, 126, 10.1007/s11095-019-2646-z Alyami, 2019, Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications, Lancet Oncol, 20, e368, 10.1016/S1470-2045(19)30318-3 Nowacki, 2018, Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study, Eur J Surg Oncol, 44, 991, 10.1016/j.ejso.2018.02.014 Van der Speeten, 2017, Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice, Pleura Peritoneum, 2, 63, 10.1515/pp-2017-0003 Miwa, 2019, Establishment of peritoneal and hepatic metastasis mouse xenograft models using gastric cancer cell lines, In Vivo, 33, 1785 Gohler, 2017, Technical description of the microinjection pump (MIP((R))) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC), Surg Endosc, 31, 1778, 10.1007/s00464-016-5174-5 Ntourakis, 2016, Adhesions and healing of intestinal anastomoses: the effect of anti-adhesion barriers, Surg Innovat, 23, 266, 10.1177/1553350615610653 Bouliaris, 2019, Adhesion prevention to polypropylene meshes using combined icodextrin four percent and dimetindene maleate, J Surg Res, 234, 325, 10.1016/j.jss.2018.10.003 Gruber-Blum, 2017, Liquid antiadhesive agents for intraperitoneal hernia repair procedures: artiss((R)) compared to CoSeal((R)) and Adept((R)) in an IPOM rat model, Surg Endosc, 31, 4973, 10.1007/s00464-016-5277-z Catena, 2012, P.O.P.A. study: prevention of postoperative abdominal adhesions by icodextrin 4% solution after laparotomy for adhesive small bowel obstruction. A prospective randomized controlled trial, J Gastrointest Surg, 16, 382, 10.1007/s11605-011-1736-y Dobbie, 1997, New principles, better practices, and clearer perceptions in intraperitoneal chemotherapy: clinical experience using icodextrin 20 as a carrier solution, Adv Perit Dial Conf, 13, 162 Hosie, 2003, A pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solution, Eur J Surg Oncol, 29, 254, 10.1053/ejso.2002.1348 Kerr, 1996, Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution, Br J Canc, 74, 2032, 10.1038/bjc.1996.672 Rocconi, 2006, Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy, Gynecol Oncol, 103, 985, 10.1016/j.ygyno.2006.06.005 Sautkin, 2019, A real-time ex vivo model (eIBUB) for optimizing intraperitoneal drug delivery as an alternative to living animal models, Pleura Peritoneum, 4, 20190017, 10.1515/pp-2019-0017 Schnelle, 2017, A new ex vivo model for optimizing distribution of therapeutic aerosols: the (inverted) bovine urinary bladder, Pleura Peritoneum, 2, 37, 10.1515/pp-2017-0006 Steuperaert, 2017, Modelling drug transport during intraperitoneal chemotherapy, Pleura Peritoneum, 2, 73, 10.1515/pp-2017-0004 Pascale, 2017, Laparoscopic subperitoneal injection of chemo-loaded particles lowers tumor growth on a rabbit model of peritoneal carcinomatosis, Tumour Biol, 39, 10.1177/1010428317698381